Clinical Trial Update: Phase 2 Trial of Bevacizumab in Combination With Pemetrexed [Phase 2]

View source ↗

Summary

This document reports the results of a Phase 2 trial evaluating bevacizumab in combination with pemetrexed for non-small cell lung cancer, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Heather Wakelee | Conditions: Non-small Cell Lung Cancer (NSCLC), Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-03-06